UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Instability in NAD+ metabolism leads to impaired cardiac mitochondrial function and communication

eLife, 2021-08, Vol.10

2021

Volltextzugriff (PDF)

Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib

Therapeutic advances in musculoskeletal disease, 2023-01, Vol.15, p.1759720X221149965-1759720X221149965

2023

Volltextzugriff (PDF)

S775 Major Cardiovascular Adverse Events by Baseline Cardiovascular Risk Stratification in Patients With Ulcerative Colitis Treated With Tofacitinib: Data From the OCTAVE Clinical Program

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e551-e552

2022

Volltextzugriff (PDF)

Chronic HIV Infection Increases Monocyte NLRP3 Inflammasome-Dependent IL-1α and IL-1β Release

International journal of molecular sciences, 2024-07, Vol.25 (13), p.7141

2024

Volltextzugriff (PDF)

Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation

PloS one, 2017-11, Vol.12 (11), p.e0188387-e0188387

2017

Volltextzugriff (PDF)

Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis

EBioMedicine, 2020-10, Vol.60, p.102985-102985, Article 102985

2020

Volltextzugriff (PDF)

NLRP3 Inflammasome Promotes Myocardial Remodeling During Diet-Induced Obesity

Frontiers in immunology, 2019, Vol.10, p.1621-1621

2019

Volltextzugriff (PDF)

Low fibre intake is associated with gut microbiota alterations in chronic heart failure

ESC Heart Failure, 2020-04, Vol.7 (2), p.456-466

2020

Volltextzugriff (PDF)

Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data

Rheumatology and therapy., 2024-06, Vol.11 (3), p.487-499

2024

Volltextzugriff (PDF)

Mammalian Target of Rapamycin (mTOR) and the Proteasome Attenuates IL-1β Expression in Primary Mouse Cardiac Fibroblasts

Frontiers in immunology, 2019, Vol.10, p.1285-1285

2019

Volltextzugriff (PDF)

Pain and Inflammation as Mediators of Tofacitinib Treatment Effect on Fatigue in Patients with Ankylosing Spondylitis: A Mediation Analysis

Rheumatology and therapy., 2023-08, Vol.10 (4), p.1073-1087

2023

Volltextzugriff (PDF)

IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction

Frontiers in immunology, 2018-09, Vol.9, p.2035-2035

2018

Volltextzugriff (PDF)

Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs

Rheumatology and therapy., 2023-04, Vol.10 (2), p.357-373

2023

Volltextzugriff (PDF)

Absence of NLRP3 Inflammasome in Hematopoietic Cells Reduces Adverse Remodeling After Experimental Myocardial Infarction

JACC. Basic to translational science, 2020-12, Vol.5 (12), p.1210-1224

2020

Volltextzugriff (PDF)

A vital role for complement in heart disease

Molecular immunology, 2014-10, Vol.61 (2), p.126-134

2014

Volltextzugriff (PDF)

TNF Revisited: Osteoprotegerin and TNF-related Molecules in Heart Failure

Current heart failure reports, 2012-06, Vol.9 (2), p.92-100

2012

Volltextzugriff (PDF)

Gut Microbiota Signature in Heart Failure Defined From Profiling of 2 Independent Cohorts

Journal of the American College of Cardiology, 2018-03, Vol.71 (10), p.1184-1186

2018

Volltextzugriff (PDF)

Increased functional capacity after 12 weeks of exercise training does not transform into improved skeletal muscle metabolism or ultrastructure in heart failure patients on modern optimal medical therapy

European journal of preventive cardiology, 2021-09, Vol.28 (9), p.e32-e37

2021

Volltextzugriff (PDF)

Su1809 ASSESSMENT OF STEROID USE IN PATIENTS WITH ACTIVE ULCERATIVE COLITIS WHO INITIATED A NEW JANUS KINASE INHIBITOR OR TUMOR NECROSIS FACTOR INHIBITOR USING DATA FROM A UNITED STATES CLAIMS DATABASE

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-823-S-824

2024

Volltextzugriff (PDF)

NLRP3 Inflammasome: A Novel Player in Metabolically Induced Inflammation—Potential Influence on the Myocardium

Journal of cardiovascular pharmacology, 2019-10, Vol.74 (4), p.276-284

2019

Volltextzugriff (PDF)

Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme

Annals of the rheumatic diseases, 2023-04, Vol.82 (4), p.575-577

2023

Volltextzugriff (PDF)

T Cells in Coronary Artery Disease

Journal of the American College of Cardiology, 2007-10, Vol.50 (15), p.1459-1461

2007

Volltextzugriff (PDF)

Reply: 1

Journal of the American College of Cardiology, 2010-05, Vol.55 (20), p.2291

2010

Volltextzugriff (PDF)

Reply

Journal of the American College of Cardiology, 2010-05, Vol.55 (20), p.2291

2010

Volltextzugriff (PDF)

Soluble Markers of Interleukin 1 Activation as Predictors of First-Time Myocardial Infarction in HIV-Infected Individuals

The Journal of infectious diseases, 2020-02, Vol.221 (4), p.506-509

2020

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

KollektionNexis Uni

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(88)
Mit Volltextzugriff
(83)

Publikationsform

Artikel
(90)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Instability in NAD+ metabolism leads to impaired cardiac mitochondrial function and communication

Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib

S775 Major Cardiovascular Adverse Events by Baseline Cardiovascular Risk Stratification in Patients With Ulcerative Colitis Treated With Tofacitinib: Data From the OCTAVE Clinical Program

Chronic HIV Infection Increases Monocyte NLRP3 Inflammasome-Dependent IL-1α and IL-1β Release

Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation

Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis

NLRP3 Inflammasome Promotes Myocardial Remodeling During Diet-Induced Obesity

Low fibre intake is associated with gut microbiota alterations in chronic heart failure

Risk Stratification of Patients with Psoriatic Arthritis and Ankylosing Spondylitis for Treatment with Tofacitinib: A Review of Current Clinical Data

Mammalian Target of Rapamycin (mTOR) and the Proteasome Attenuates IL-1β Expression in Primary Mouse Cardiac Fibroblasts

Pain and Inflammation as Mediators of Tofacitinib Treatment Effect on Fatigue in Patients with Ankylosing Spondylitis: A Mediation Analysis

IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction

Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs

Absence of NLRP3 Inflammasome in Hematopoietic Cells Reduces Adverse Remodeling After Experimental Myocardial Infarction

A vital role for complement in heart disease

TNF Revisited: Osteoprotegerin and TNF-related Molecules in Heart Failure

Gut Microbiota Signature in Heart Failure Defined From Profiling of 2 Independent Cohorts

Increased functional capacity after 12 weeks of exercise training does not transform into improved skeletal muscle metabolism or ultrastructure in heart failure patients on modern optimal medical therapy

Su1809 ASSESSMENT OF STEROID USE IN PATIENTS WITH ACTIVE ULCERATIVE COLITIS WHO INITIATED A NEW JANUS KINASE INHIBITOR OR TUMOR NECROSIS FACTOR INHIBITOR USING DATA FROM A UNITED STATES CLAIMS DATABASE

NLRP3 Inflammasome: A Novel Player in Metabolically Induced Inflammation—Potential Influence on the Myocardium

Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme

T Cells in Coronary Artery Disease

Reply: 1

Reply

Soluble Markers of Interleukin 1 Activation as Predictors of First-Time Myocardial Infarction in HIV-Infected Individuals

Aktive Filter

Suchergebnisse filtern